Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emilia Cocorocchio
Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study
Frontiers in Immunology
Allergy
Immunology
Related publications
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated With Ipilimumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab
Journal of Cutaneous Immunology and Allergy
Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma
Cancer immunology research
Cancer Research
Immunology
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
Site‐specific Response Patterns, Pseudoprogression, and Acquired Resistance in Patients With Melanoma Treated With Ipilimumab Combined With Anti–PD‐1 Therapy
Cancer
Cancer Research
Oncology
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-Ctla-4 Therapy in Metastatic Melanoma From the Ipilimumab Network
PLoS ONE
Multidisciplinary
Late Development of Splenic Sarcoidosis-Like Lesions in a Patient With Metastatic Melanoma and Long-Lasting Clinical Response to Ipilimumab
OncoImmunology
Oncology
Allergy
Immunology
